DiRaimondo Thomas

Chief Scientific Officer at JANX

Sold, on record
$266k
Dollars the filings state
Form 4 sales
2
Latest Jan 2, 2026
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • JANXJanux Therapeutics, Inc.Chief Scientific Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice JANXNotice
    Sep 27, 2024 2024

    Filed to sell 5,000 shares ($233k)

    DiRaimondo Thomas, Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale JANXRoutine
    Sep 27, 2024 same day

    Sold 5,000 shares at $46.35 ($232k)

    DiRaimondo Thomas, Chief Scientific Officer

    10b5-1 planSold 4.9% of holdings ($4.8M position)97,938 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 sale JANXNo plan
    Jan 2, 2026 +462 days

    Sold 2,505 shares at $13.73 ($34k)

    DiRaimondo Thomas, Chief Scientific Officer

    No 10b5-1 planSold 2% of holdings ($1.7M position)124,425 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by DiRaimondo Thomas
Source
Jan 2, 2026Jan 2, 2026JANXChief Scientific OfficerForm 4 sale2,505$34k2.0%No planSEC
Sep 27, 2024Sep 27, 2024JANXChief Scientific OfficerForm 4 sale5,000$232k4.9%RoutineSEC
Sep 27, 2024Sep 27, 2024JANXOfficerForm 144 notice5,000$233kNoticeSEC